Using light and algae to create important medicines
Harnessing light and model endosymbiosis to produce natural products
['FUNDING_R01'] · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · NIH-11099298
This study is exploring a new way to make important medicines like antibiotics and cancer treatments by teaming up special bacteria and yeast, using sunlight to help them work together, which could be better for the environment than current methods.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN (nih funded) |
| Locations | 1 site (CHAMPAIGN, UNITED STATES) |
| Trial ID | NIH-11099298 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a sustainable method to produce valuable natural products, such as antibiotics and anticancer agents, by harnessing light energy and the unique properties of cyanobacteria and yeast. The approach involves creating a symbiotic relationship between cyanobacteria and yeast cells, where the cyanobacteria provide energy and carbon through photosynthesis, enabling the yeast to synthesize complex drugs. By utilizing this innovative biocatalytic platform, the research aims to overcome the challenges of traditional drug production methods that rely on plants or petrochemicals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new antibiotic and anticancer therapies, particularly those with conditions that are currently difficult to treat.
Not a fit: Patients who are not affected by bacterial infections or cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and sustainable production of essential medicines, improving access to life-saving treatments.
How similar studies have performed: Other research has shown promise in using similar biotechnological approaches to produce natural products, indicating potential for success in this novel application.
Where this research is happening
CHAMPAIGN, UNITED STATES
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — CHAMPAIGN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MEHTA, ANGAD — UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- Study coordinator: MEHTA, ANGAD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents